in ,

RELI Group Secures CMS Contract for Medicare Drug Price Negotiations Oversight

RELI Group company logo
RELI Group secures CMS Contract for drug price auditing work.

RELI Group has won a five-year, nearly $60 million contract to provide monitoring, oversight, compliance and auditing services for the Centers for Medicare and Medicaid Services. Work on the contract begins May 2, RELI Group said Tuesday.

Contract Award Details

The MOCA contract supports the Medicare Drug Price Negotiation Program, an initiative established under the Inflation Reduction Act that enables Medicare to negotiate lower prices on select high-cost prescription drugs.

The contract was awarded through a competitive acquisition process, with seven bids submitted.

Mohammad Elias, RELI Group founder and CEO, commented, “We are honored to have been selected by CMS to support this critical initiative aimed at enhancing transparency and accountability in Medicare drug pricing.”

In August 2024, RELI also received a 10-year, $33 million CMS contract to oversee the Making Care Primary model, a program focused on improving access to and quality of primary care for Medicare beneficiaries.

ExecutiveBiz Logo

Sign Up Now! ExecutiveBiz provides you with Daily Updates and News Briefings about Contract Awards

mm

Written by Kacey Roberts

Bill Wall, Accrete AI Government CEO
Accrete’s Bill Wall: Advanced Tech Could Help Uncover FOCI Risks to Defense Industrial Base
Handshake representing partnership
Rancher Government & DPG to Support Federal IT Modernization